Rexer Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 1996.
1996 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Rexer Pharma Private Limited

Rexer Pharma Private Limited, a active private limited company, was established on 20 December 1996 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG1996PTC026005. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.

It upholds a compliant status. Employing 16 professional, Its leadership includes Sujana Seelam (Director), Madallapalli Surya Mohan (Director), Raghava Reddy Gureddygari (Director). Past directors included Sujana Seelam, Seelam Sreenivas Reddy. It holds no open charges and ₹1.51 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 114/2/B, Phase-Ii, Ida, Cherlapally, Hyderabad, Telangana, 500051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG1996PTC026005

  • Registration Number

    026005

  • Incorporation Date

    20 December 1996

  • Authorized Capital

    ₹4.00 M

  • Paid-Up Capital

    ₹4.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.00 M
  • Paid Up Capital ₹ 4.00 M
  • Company Age 29 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.51 Cr
  • Revenue Growth **** 8.09%
  • Profit Growth **** 53.15%
  • Ebitda **** 162.02%
  • Net Worth 1.09%
  • Total Assets **** 6.01%
Company report

Rexer Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rexer Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rexer Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sujana Seelam Director 23 Jan 2017 Current
Madallapalli Surya Mohan Director 20 Dec 1996 Current
Raghava Reddy Gureddygari Director 20 Dec 1996 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Director 29 Jul 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rexer Pharma.

Rexer Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.09% increase. The company also saw a substantial improvement in profitability, with a 53.15% increase in profit. The company's net worth moved up by a moderate rise of 1.09%.

Rexer Pharma revenue growth over time
Rexer Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.09%
*******
*******
*******
*******
Revenue from Operations
*******
 8.25%
*******
*******
*******
*******
Total Assets
*******
 6.01%
*******
*******
*******
*******
Profit or Loss
*******
 53.15%
*******
*******
*******
*******
Net Worth
*******
 1.09%
*******
*******
*******
*******
EBITDA
*******
 162.02%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rexer Pharma?

Unlock access to Rexer Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹15,100,000.00

Charges Breakdown by Lending Institutions
  • A. P. State Financial Corporation : 0.76 Cr
  • Andhra Pradesh State Financial Corporation : 0.40 Cr
  • Others : 0.35 Cr
Latest Charge Details
Date Lender Amount Status
09 Mar 2016 Others ₹1.50 M Satisfied
30 Mar 2010 Andhra Pradesh State Financial Corporation ₹4.00 M Satisfied
20 Jul 2007 Others ₹2.00 M Satisfied
18 Mar 2005 A. P. State Financial Corporation ₹7.60 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Rexer Pharma?

Rexer Pharma has a workforce of 16 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rexer Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexer Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rexer Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Rexer Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Rexer Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    A charge registered on 09 Mar 2016 via Charge ID 100022033 with Others was fully satisfied on 27 Oct 2023. was recorded as a recent event.

  • Charges

    The activity A charge registered on 20 Jul 2007 via Charge ID 10097532 with Others was fully satisfied on 27 Oct 2023. was completed.

  • Director Appointment

    The activity Sujana Seelam was appointed as a Director was appointed as a Director on 23 Jan 2017 & has been associated with this company since 9 years 17 days . was completed.

  • Charges

    The activity A charge registered on 30 Mar 2010 via Charge ID 10213732 with Andhra Pradesh State Financial Corporation was fully satisfied on 18 Apr 2016. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rexer Pharma Private Limited?

The CIN of Rexer Pharma Private Limited is U24230TG1996PTC026005.

Where is Rexer Pharma Private Limited headquartered?

Rexer Pharma Private Limited is headquartered at 114/2/B, Phase-Ii, Ida, Cherlapally, Hyderabad, Telangana, 500051.

When was Rexer Pharma Private Limited incorporated?

Rexer Pharma Private Limited was incorporated on 20 December 1996.

Who are the current directors of Rexer Pharma Private Limited?

The current directors of Rexer Pharma Private Limited are

What is the primary industry of Rexer Pharma Private Limited?

The primary industry of Rexer Pharma Private Limited is Manufacturing.

Is Rexer Pharma Private Limited a listed company?

Rexer Pharma Private Limited is unlisted.

What is the capital structure of Rexer Pharma Private Limited?

The authorized capital of Rexer Pharma Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.

What is the compliance status of Rexer Pharma Private Limited?

The compliance status of Rexer Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available